Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 05, 2016; 86 (16 Supplement) April 20, 2016

Amyotrophic Lateral Sclerosis Mortality in the United States, 2011-2013 (P5.087)

Theodore Larson, Wendy Kaye, Paul Mehta, Kevin Horton
First published April 4, 2016,
Theodore Larson
2National ALS Registry, CDC/ATSDR Atlanta GA United States
3National ALS Registry, CDC/ATSDR Atlanta GA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendy Kaye
1McKing Consulting Corporation Atlanta GA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Mehta
2National ALS Registry, CDC/ATSDR Atlanta GA United States
3National ALS Registry, CDC/ATSDR Atlanta GA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Horton
2National ALS Registry, CDC/ATSDR Atlanta GA United States
3National ALS Registry, CDC/ATSDR Atlanta GA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
Amyotrophic Lateral Sclerosis Mortality in the United States, 2011-2013 (P5.087)
Theodore Larson, Wendy Kaye, Paul Mehta, Kevin Horton
Neurology Apr 2016, 86 (16 Supplement) P5.087;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: To determine mortality rates for ALS in the United States, 2011-2013, using International Classification of Disease, 10th Revision (ICD-10), code G12.2, Motor Neuron Disease (MND), and excluding deaths from causes other than ALS. Background: Unlike the 9th Revision, ICD-10 does not include a code specific for ALS. In addition, other non-MND conditions (e.g., supranuclear palsy) were assigned to G12.2. Past mortality studies have reported rates for G12.2 without excluding those that were not ALS which leads to inflated mortality rates. This analysis focuses only on the mortality for ALS. Methods: Mortality data for ALS were obtained from the Centers for Disease Control and Prevention, National Center for Health Statistics, for the period 2011-2013. Text strings for multiple-cause-of death were reviewed for all deaths with a code of G12.2. Deaths without ALS listed in one of the multiple-cause of death fields were excluded. ALS death rates per 100,000 persons were age-adjusted to the 2000 US standard population. Results: Approximately 21[percnt] of ICD-10 code G12.2 deaths in each year were not ALS, the majority being supranuclear palsy. There were 18,036 ALS deaths in the US during 2011-2013, mostly white (n=16,487; 91[percnt]) and male (n=10,065; 56[percnt]). The overall death rate was 1.7 per 100,000 persons (95[percnt] CI 1.7, 1.7). The death rate for males was 2.1 per 100,000 persons (95[percnt] CI 2.0, 2.1) and for females was 1.4 per 100,000 persons (95[percnt] CI 1.4, 1.4). Conclusions: Previous reports of ALS mortality in the U.S., showed similar age, sex, and race distributions. However, other reports showed slightly greater age-adjusted mortality rates due to the inclusion of other diseases in the case definition. Until there is a specific ICD-10 code for ALS, an additional review of multiple-cause of death data is required to give an accurate estimate of ALS deaths in the United States.

Disclosure: Dr. Larson has nothing to disclose. Dr. Kaye has received personal compensation for activities with McKing Consulting Corporation as an employee. Dr. Mehta has nothing to disclose. Dr. Horton has nothing to disclose.

Wednesday, April 20 2016, 8:30 am-7:00 pm

  • Copyright © 2016 by AAN Enterprises, Inc.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 99 (1)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise